Publications by authors named "Per Edlund"

Claim this Profile
L
Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1.
Paula Poikonen-Saksela, Henrik Lindman, Asgerdur Sverrisdottir, Per Edlund, Kenneth Villman

Acta Oncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer.
Alexios Matikas, Sara Margolin, Mats Hellström, Hemming Johansson, Nils-Olof Bengtsson, Per Edlund

Breast Cancer Res Treat· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inter-observer variation in delineating the coronary arteries as organs at risk.
Anna-Karin Wennstig, Hans Garmo, Per Hållström, Petra Witt Nyström, Per Edlund

Radiother Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy.
Georg Holgersson, Stefan Bergström, Per Liv, Jonas Nilsson, Per Edlund

Anticancer Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.
Carl Blomberg, Jonas Nilsson, Georg Holgersson, Per Edlund, Michael Bergqvist

Anticancer Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1.
Per Edlund, Johan Ahlgren, Karsten Bjerre, Michael Andersson, Jonas Bergh

Acta Oncol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer.
Sara Margolin, Nils-Olof Bengtsson, Lena Carlsson, Per Edlund, Mats Hellstrøm

Acta Oncol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.
Bent Kristensen, Bent Ejlertsen, Henning T Mouridsen, Maj-Britt Jensen, Jørn Andersen, Per Edlund

Acta Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer.
Bent Ejlertsen, Henning T Mouridsen, Maj-Britt Jensen, Jørn Andersen, Søren Cold, Per Edlund

Eur J Cancer· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar efficacy for ovarian ablation compared with cyclophosphamide, methotrexate, and fluorouracil: from a randomized comparison of premenopausal patients with node-positive, hormone receptor-positive breast cancer.
Bent Ejlertsen, Henning T Mouridsen, Maj-Britt Jensen, Nils-Olof Bengtsson, Jonas Bergh, Per Edlund

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
Pawel Baranczewski, Per Olof Edlund, Hans Postlind

J Pharm Biomed Anal· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of corticosteroids in tissue samples by liquid chromatography-tandem mass spectrometry.
Yuko Rönquist-Nii, Per Olof Edlund

J Pharm Biomed Anal· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer on the Internet: the quality of Swedish breast cancer websites.
Elisabeth Nilsson-Ihrfelt, Marie-Louise Fjällskog, Carl Blomqvist, Johan Ahlgren, Per Edlund

Breast· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of BVT.2938 metabolites by LC/MS and LC/MS/MS after in vitro incubations with liver microsomes and hepatocytes.
Per Olof Edlund, Pawel Baranczewski

J Pharm Biomed Anal· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis